Read + Share
Amedeo Smart
Independent Medical Education
Roberts C, Strauss VY, Kopijasz S, Gourley C, et al. Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours. Br J Cancer 2020;122:483-490.PMID: 31813938
Email
LinkedIn
Facebook
Twitter
Privacy Policy